Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

LEADING

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 34
  • 0 comments

FDA approve IMIPRAMINE HYDROCHLORIDE

Comment Full text

RUBICON

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 32
  • 0 comments

FDA approve TRAMADOL HYDROCHLORIDE

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 31
  • 0 comments

FDA approve LAMIVUDINE

Comment Full text

SUN PHARM INDS

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 29
  • 0 comments

FDA approve DIVALPROEX SODIUM

Comment Full text

HERITAGE PHARMS INC

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 30
  • 0 comments

FDA approve HYDRALAZINE HYDROCHLORIDE

Comment Full text

PERRIGO

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 30
  • 0 comments

FDA approve DOXYLAMINE SUCCINATE

Comment Full text

LEADING

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 31
  • 0 comments

FDA approve HYDROCHLOROTHIAZIDE

Comment Full text

RISE PHARMA

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 27
  • 0 comments

FDA approve HYDROXYCHLOROQUINE SULFATE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Oct. 11, 2023, 11:45 UTC
  • 31
  • 0 comments

FDA approve LAMIVUDINE

Comment Full text

NOVARTIS PHARMS CORP

  • FDA Approval
  • Oct. 11, 2023, 00:07 UTC
  • 33
  • 0 comments

FDA approve SECUKINUMAB

Comment Full text
  • Previous
  • 660
  • 661
  • 662
  • 663
  • 664
  • Next

Search

News categories

  • Technical Exchange News(11989)
  • Event(5066)
  • SEC News(247868)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(149059)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin